Trial Profile
Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha-2a (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 14 Jul 2014 New trial record